IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — BRTX

Balance Sheet

(in millions USD)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents3.110.601.561.231.492.251.162.441.781.846.57----------
Short-term Investments0.483.895.837.8811.6012.4315.269.809.8310.549.91----------
Accounts Receivable0.010.010.020.030.170.030.040.040.030.020.050.020.020.010.020.02
Total Current Assets3.804.717.609.3613.5115.0016.7712.6012.0412.7816.8918.3219.881.171.832.59
Property, Plant & Equipment0.330.310.340.370.380.350.370.310.310.300.230.270.140.010.010.02
Intangible Assets0.510.560.580.600.650.670.690.740.760.780.530.550.570.610.630.65
Total Non-current Assets*0.840.940.920.971.061.121.181.201.261.301.031.121.041.011.061.11
Total Assets4.645.648.5210.3314.5716.1217.9513.8013.3014.0817.9219.4420.922.182.883.70
Accounts Payable0.670.860.610.600.400.220.230.230.280.090.470.380.210.120.100.25
Total Current Liabilities1.613.443.674.184.585.323.450.930.810.470.720.620.490.871.331.29
Long-term Debt--------------------------10.299.589.68
Total Non-current Liabilities*0.000.000.000.000.000.000.000.040.080.120.200.230.276.185.375.10
Total Liabilities*1.613.443.674.184.585.323.450.980.900.590.920.860.767.056.696.40
Retained Earnings(172.08)(166.71)(163.67)(161.02)(154.04)(152.95)(148.92)(164.23)(161.31)(158.33)(148.29)(143.64)(138.96)(113.74)(109.56)(105.50)
Total Stockholder Equity3.032.214.856.149.9910.8014.5012.8312.4013.4917.0018.5920.16(4.88)(3.81)(2.69)

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Total Revenue0.020.020.010.300.030.040.230.090.040.020.030.060.030.000.030.070.020.010.010.02
Cost of Revenue0.010.000.010.010.000.000.020.01------------------------
Gross Profit0.020.020.000.290.020.040.220.08------------------------
Research & Development1.933.562.592.231.711.681.321.291.060.680.870.971.510.670.991.080.780.170.240.16
Selling, General & Admin1.480.281.121.373.121.051.181.263.092.562.262.214.304.133.653.594.213.783.463.40
Total Operating Expenses3.403.843.713.604.832.732.502.554.143.243.143.185.814.694.644.705.074.013.703.57
Operating Income(3.39)(3.83)(3.71)(3.31)(4.81)(2.69)(2.29)(2.47)(4.11)(3.22)(3.10)(3.12)(5.78)(4.68)(4.61)(4.63)(5.05)(4.01)(3.69)(3.56)
Interest Expense----------------------------0.03----------
Net Income(2.15)(3.21)(3.04)(2.66)(5.34)(1.64)(1.09)(4.03)(2.22)1.17(2.93)(2.98)(5.68)(4.35)(4.66)(4.68)(4.82)(20.40)(4.18)(4.06)
Basic EPS(0.12)(0.31)(0.33)(0.30)(0.64)(0.20)(0.13)(0.50)(0.33)(0.48)(0.64)(0.77)(1.53)(1.18)(1.28)(1.28)(1.37)------
Diluted EPS(0.12)(0.31)(0.33)(0.30)(0.64)(0.20)(0.13)(0.50)(0.33)(0.57)(0.64)(0.77)----------------

Cash Flow Statement

(in millions USD)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow(3.81)(2.42)(2.90)(2.69)(2.78)(2.35)(1.70)(1.87)(2.32)(1.77)(1.18)(1.13)(2.35)(1.57)(1.45)(1.25)(1.59)(1.15)(0.63)(0.74)
Capital Expenditures--0.080.000.000.040.010.060.04--0.070.010.030.06--(0.02)0.140.11------
Free Cash Flow*--(2.49)(2.90)(2.69)(2.82)(2.36)(1.76)(1.90)--(1.84)(1.19)(1.16)(2.41)--(1.43)(1.39)(1.70)------
Investing Cash Flow0.972.402.002.132.371.530.942.97(4.93)0.10(0.02)0.672.51(3.32)(9.91)(0.14)(0.11)------
Financing Cash Flow4.440.92(0.05)0.891.09(0.13)0.00(0.01)7.520.081.850.41----------21.070.000.00

* Derived from reported values